{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:37Z","timestamp":1792784977075,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["21KK0163"],"award-info":[{"award-number":["21KK0163"]}]},{"name":"JSPS KAKENHI","award":["22H03290"],"award-info":[{"award-number":["22H03290"]}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K08 AR079615"],"award-info":[{"award-number":["K08 AR079615"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH Autoimmune Centers of Excellence","award":["U19 AI 110495"],"award-info":[{"award-number":["U19 AI 110495"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sj\u00f6gren\u2019s syndrome is a chronic autoimmune disorder whose pathogenesis is poorly understood and that lacks effective therapies. Detailed quantitative and spatial analyses of tissues affected by Sj\u00f6gren\u2019s syndrome were undertaken, including the quantitation of the frequency of selected cell\u2013cell interactions in the disease milieu. Quantitative analyses of CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell subsets and of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells in the labial salivary glands from untreated patients with primary Sj\u00f6gren\u2019s syndrome revealed that activated CD8\n                    <jats:sup>+<\/jats:sup>\n                    cytotoxic T cells (CD8\n                    <jats:sup>+<\/jats:sup>\n                    CTLs) were the most prominent T cells in these infiltrates. An accumulation of apoptotic glandular epithelial cells, mainly ductal and acinar cells, was observed, consistent with the impaired salivary secretion often observed in patients with this disease. FasL expressing activated CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells were seen to accumulate around Fas expressing apoptotic epithelial cells. Quantitative analyses of apoptotic cell types and of conjugates between cytotoxic T cells and epithelial cells undergoing apoptosis suggest that Sj\u00f6gren\u2019s syndrome is primarily driven by CD8\n                    <jats:sup>+<\/jats:sup>\n                    CTL mediated execution of epithelial cells mainly represented by ductal and acinar cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-19397-w","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T06:04:52Z","timestamp":1663135492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1038","volume":"12","author":[{"given":"Naoki","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory A.","family":"Perugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Munemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsei","family":"Sameshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Diefenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Premo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Chinju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"19397_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox, R. I. Sjogren\u2019s syndrome. Lancet 366, 321\u2013331. https:\/\/doi.org\/10.1016\/s0140-6736(05)66990-5 (2005).","journal-title":"Lancet"},{"key":"19397_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino, F. B. et al. New treatment guidelines for Sjogren\u2019s disease. Rheum. Dis. Clin. N. Am. 42, 531\u2013551. https:\/\/doi.org\/10.1016\/j.rdc.2016.03.010 (2016).","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"19397_CR3","doi-asserted-by":"publisher","first-page":"832789","DOI":"10.1155\/2013\/832789","volume":"2013","author":"A Menendez","year":"2013","unstructured":"Menendez, A. et al. Common and specific associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies in systemic lupus erythematosus. TheScientificWorldJOURNAL 2013, 832789. https:\/\/doi.org\/10.1155\/2013\/832789 (2013).","journal-title":"TheScientificWorldJOURNAL"},{"key":"19397_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/art.40093","volume":"69","author":"SJ Bowman","year":"2017","unstructured":"Bowman, S. J. et al. Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 69, 1440\u20131450. https:\/\/doi.org\/10.1002\/art.40093 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"19397_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/m13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec, V. et al. Treatment of primary Sj\u00f6gren syndrome with rituximab: A randomized trial. Ann. Intern. Med. 160, 233\u2013242. https:\/\/doi.org\/10.7326\/m13-1085 (2014).","journal-title":"Ann. Intern. Med."},{"key":"19397_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/annrheumdis-2017-212268","volume":"77","author":"BA Fisher","year":"2018","unstructured":"Fisher, B. A. et al. Effect of rituximab on a salivary gland ultrasound score in primary Sj\u00f6gren\u2019s syndrome: Results of the TRACTISS randomised double-blind multicentre substudy. Ann. Rheum. Dis. 77, 412\u2013416. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212268 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clim.2017.05.002","volume":"182","author":"GM Verstappen","year":"2017","unstructured":"Verstappen, G. M., van Nimwegen, J. F., Vissink, A., Kroese, F. G. M. & Bootsma, H. The value of rituximab treatment in primary Sjogren\u2019s syndrome. Clin. Immunol. 182, 62\u201371. https:\/\/doi.org\/10.1016\/j.clim.2017.05.002 (2017).","journal-title":"Clin. Immunol."},{"key":"19397_CR8","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/art.37850","volume":"65","author":"EW St Clair","year":"2013","unstructured":"St Clair, E. W. et al. Rituximab therapy for primary Sjogren\u2019s syndrome: An open-label clinical trial and mechanistic analysis. Arthritis Rheum. 65, 1097\u20131106. https:\/\/doi.org\/10.1002\/art.37850 (2013).","journal-title":"Arthritis Rheum."},{"key":"19397_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2249.2012.04606.x","volume":"169","author":"T Maehara","year":"2012","unstructured":"Maehara, T. et al. Selective localization of T helper subsets in labial salivary glands from primary Sjogren\u2019s syndrome patients. Clin. Exp. Immunol. 169, 89\u201399. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04606.x (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"19397_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01869.x","volume":"128","author":"DI Mitsias","year":"2002","unstructured":"Mitsias, D. I. et al. The Th1\/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren\u2019s syndrome. Clin. Exp. Immunol. 128, 562\u2013568. https:\/\/doi.org\/10.1046\/j.1365-2249.2002.01869.x (2002).","journal-title":"Clin. Exp. Immunol."},{"issue":"Suppl 126","key":"19397_CR11","first-page":"222","volume":"38","author":"E Pontarini","year":"2020","unstructured":"Pontarini, E. et al. Blocking T cell co-stimulation in primary Sj\u00f6gren\u2019s syndrome: Rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers. Clin. Exp. Rheumatol. 38(Suppl 126), 222\u2013227 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"19397_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101547","author":"E Pontarini","year":"2021","unstructured":"Pontarini, E., Coleby, R. & Bombardieri, M. Cellular and molecular diversity in Sjogren\u2019s syndrome salivary glands: Towards a better definition of disease subsets. Semin. Immunol. https:\/\/doi.org\/10.1016\/j.smim.2021.101547 (2021).","journal-title":"Semin. Immunol."},{"key":"19397_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/mi.2013.61","volume":"7","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. CD8+ cells regulate the T helper-17 response in an experimental murine model of Sj\u00f6gren syndrome. Mucosal Immunol. 7, 417\u2013427. https:\/\/doi.org\/10.1038\/mi.2013.61 (2014).","journal-title":"Mucosal Immunol."},{"key":"19397_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/sarh.2002.33724","volume":"32","author":"M Ramos-Casals","year":"2002","unstructured":"Ramos-Casals, M. et al. Th1\/Th2 cytokine imbalance in patients with Sj\u00f6gren syndrome secondary to hepatitis C virus infection. Semin. Arthritis Rheum. 32, 56\u201363. https:\/\/doi.org\/10.1053\/sarh.2002.33724 (2002).","journal-title":"Semin. Arthritis Rheum."},{"key":"19397_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","volume":"87","author":"GM Verstappen","year":"2018","unstructured":"Verstappen, G. M., Corneth, O. B. J., Bootsma, H. & Kroese, F. G. M. Th17 cells in primary Sj\u00f6gren\u2019s syndrome: Pathogenicity and plasticity. J. Autoimmun. 87, 16\u201325. https:\/\/doi.org\/10.1016\/j.jaut.2017.11.003 (2018).","journal-title":"J. Autoimmun."},{"key":"19397_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.40424","volume":"70","author":"VR Fonseca","year":"2018","unstructured":"Fonseca, V. R. et al. The ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 70, 774\u2013784. https:\/\/doi.org\/10.1002\/art.40424 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"19397_CR17","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","volume":"79","author":"E Pontarini","year":"2020","unstructured":"Pontarini, E. et al. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj\u00f6gren\u2019s syndrome with ectopic germinal centres and MALT lymphoma. Ann. Rheum. Dis. 79, 1588\u20131599. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217646 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR18","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1136\/annrheumdis-2015-208304","volume":"75","author":"K Delli","year":"2016","unstructured":"Delli, K. et al. Towards personalised treatment in primary Sj\u00f6gren\u2019s syndrome: Baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann. Rheum. Dis. 75, 1933\u20131938. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208304 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13075-016-0924-2","volume":"18","author":"S Costa","year":"2016","unstructured":"Costa, S. et al. B-cell and T-cell quantification in minor salivary glands in primary Sj\u00f6gren\u2019s syndrome: Development and validation of a pixel-based digital procedure. Arthritis Res. Ther. 18, 21. https:\/\/doi.org\/10.1186\/s13075-016-0924-2 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"19397_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/art.41289","volume":"72","author":"D Lucchesi","year":"2020","unstructured":"Lucchesi, D. et al. Impaired interleukin-27-mediated control of CD4+ T cell function impact on ectopic lymphoid structure formation in patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 72, 1559\u20131570. https:\/\/doi.org\/10.1002\/art.41289 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"19397_CR21","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","volume":"179","author":"M Bombardieri","year":"2007","unstructured":"Bombardieri, M. et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sj\u00f6gren\u2019s syndrome. J. Immunol. 179, 4929\u20134938. https:\/\/doi.org\/10.4049\/jimmunol.179.7.4929 (2007).","journal-title":"J. Immunol."},{"key":"19397_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2249.1998.00705.x","volume":"114","author":"M Polihronis","year":"1998","unstructured":"Polihronis, M. et al. Modes of epithelial cell death and repair in Sjogren\u2019s syndrome (SS). Clin. Exp. Immunol. 114, 485\u2013490. https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00705.x (1998).","journal-title":"Clin. Exp. Immunol."},{"key":"19397_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/art.1780400113","volume":"40","author":"L Kong","year":"1997","unstructured":"Kong, L. et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren\u2019s symdrome. Arthritis Rheum. 40, 87\u201397 (1997).","journal-title":"Arthritis Rheum."},{"key":"19397_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/sarh.2003.50019","volume":"33","author":"P Manganelli","year":"2003","unstructured":"Manganelli, P. & Fietta, P. Apoptosis and Sjogren syndrome. Semin. Arthritis Rheum. 33, 49\u201365. https:\/\/doi.org\/10.1053\/sarh.2003.50019 (2003).","journal-title":"Semin. Arthritis Rheum."},{"key":"19397_CR25","unstructured":"Rischmueller, M. et al. Salivary gland apoptosis in primary Sjogren\u2019s syndrome: a controlled study. In Arthritis and Rheumatism Vol. 41 (1998)."},{"key":"19397_CR26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3899\/jrheum.090866","volume":"37","author":"G Hern\u00e1ndez-Molina","year":"2010","unstructured":"Hern\u00e1ndez-Molina, G. et al. Similarities and differences between primary and secondary Sj\u00f6gren\u2019s syndrome. J. Rheumatol. 37, 800\u2013808. https:\/\/doi.org\/10.3899\/jrheum.090866 (2010).","journal-title":"J. Rheumatol."},{"key":"19397_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara, H. et al. A novel clinical entity, IgG4-related disease (IgG4RD): General concept and details. Mod. Rheumatol. 22, 1\u201314. https:\/\/doi.org\/10.1007\/s10165-011-0508-6 (2012).","journal-title":"Mod. Rheumatol."},{"key":"19397_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo, H. et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J. Allergy Clin. Immunol. 138, 825\u2013838. https:\/\/doi.org\/10.1016\/j.jaci.2015.12.1330 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"19397_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","volume":"76","author":"T Maehara","year":"2017","unstructured":"Maehara, T. et al. Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. Ann. Rheum. Dis. 76, 377\u2013385. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209139 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749\u2013761. https:\/\/doi.org\/10.1038\/nri3307 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"19397_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7548","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science https:\/\/doi.org\/10.1126\/science.aaz7548 (2020).","journal-title":"Science"},{"key":"19397_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2249.2004.02686.x","volume":"139","author":"E Mavoungou","year":"2005","unstructured":"Mavoungou, E., Bouyou-Akotet, M. K. & Kremsner, P. G. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin. Exp. Immunol. 139, 287\u2013296. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02686.x (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"19397_CR33","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1073\/pnas.85.11.3985","volume":"85","author":"Y Bushkin","year":"1988","unstructured":"Bushkin, Y., Demaria, S., Le, J. M. & Schwab, R. Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. Proc. Natl. Acad. Sci. USA. 85, 3985\u20133989. https:\/\/doi.org\/10.1073\/pnas.85.11.3985 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"19397_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter, A. G. & Janicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99\u2013104. https:\/\/doi.org\/10.1038\/sj.cdd.4400476 (1999).","journal-title":"Cell Death Differ."},{"key":"19397_CR35","doi-asserted-by":"publisher","first-page":"G247","DOI":"10.1152\/ajpgi.2001.281.1.G247","volume":"281","author":"V Gresz","year":"2001","unstructured":"Gresz, V. et al. Identification and localization of aquaporin water channels in human salivary glands. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G247-254. https:\/\/doi.org\/10.1152\/ajpgi.2001.281.1.G247 (2001).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"19397_CR36","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1111\/odi.12239","volume":"21","author":"V Gresz","year":"2015","unstructured":"Gresz, V., Horvath, A., Gera, I., Nielsen, S. & Zelles, T. Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sj\u00f6gren\u2019s syndrome. Oral Dis. 21, e114-120. https:\/\/doi.org\/10.1111\/odi.12239 (2015).","journal-title":"Oral Dis."},{"key":"19397_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061547","author":"C D'Agostino","year":"2020","unstructured":"D\u2019Agostino, C. et al. Insight into salivary gland aquaporins. Cells https:\/\/doi.org\/10.3390\/cells9061547 (2020).","journal-title":"Cells"},{"key":"19397_CR38","doi-asserted-by":"publisher","first-page":"6936727","DOI":"10.1155\/2018\/6936727","volume":"2018","author":"I Puxeddu","year":"2018","unstructured":"Puxeddu, I. et al. Salivary gland pathology in IgG4-related disease: A comprehensive review. J. Immunol. Res. 2018, 6936727. https:\/\/doi.org\/10.1155\/2018\/6936727 (2018).","journal-title":"J. Immunol. Res."},{"key":"19397_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/jci131700","author":"T Maehara","year":"2020","unstructured":"Maehara, T. et al. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis. J. Clin. Investig. https:\/\/doi.org\/10.1172\/jci131700 (2020).","journal-title":"J. Clin. Investig."},{"key":"19397_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.022","author":"CA Perugino","year":"2020","unstructured":"Perugino, C. A. et al. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.022 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"19397_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/s0960-9822(00)00207-4","volume":"4","author":"PA Henkart","year":"1994","unstructured":"Henkart, P. A. & Sitkovsky, M. V. Cytotoxic lymphocytes. Two ways to kill target cells. Curr. Biol. 4, 923\u2013925. https:\/\/doi.org\/10.1016\/s0960-9822(00)00207-4 (1994).","journal-title":"Curr. Biol."},{"key":"19397_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/6.3.347","volume":"6","author":"T Renno","year":"1994","unstructured":"Renno, T. et al. Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int. Immunol. 6, 347\u2013354. https:\/\/doi.org\/10.1093\/intimm\/6.3.347 (1994).","journal-title":"Int. Immunol."},{"key":"19397_CR43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.154.2.944","volume":"154","author":"T Renno","year":"1995","unstructured":"Renno, T., Krakowski, M., Piccirillo, C., Lin, J. Y. & Owens, T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154, 944\u2013953 (1995).","journal-title":"J. Immunol."},{"key":"19397_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529\u2013542. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.004 (2014).","journal-title":"Immunity"},{"key":"19397_CR45","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"SS Kassan","year":"2004","unstructured":"Kassan, S. S. & Moutsopoulos, H. M. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch. Intern. Med. 164, 1275\u20131284. https:\/\/doi.org\/10.1001\/archinte.164.12.1275 (2004).","journal-title":"Arch. Intern. Med."},{"key":"19397_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/01.bor.0000172801.56744.c3","volume":"17","author":"A Hansen","year":"2005","unstructured":"Hansen, A., Lipsky, P. E. & Dorner, T. Immunopathogenesis of primary Sjogren\u2019s syndrome: Implications for disease management and therapy. Curr. Opin. Rheumatol. 17, 558\u2013565. https:\/\/doi.org\/10.1097\/01.bor.0000172801.56744.c3 (2005).","journal-title":"Curr. Opin. Rheumatol."},{"key":"19397_CR47","doi-asserted-by":"publisher","first-page":"e114575","DOI":"10.1371\/journal.pone.0114575","volume":"9","author":"E Corsiero","year":"2014","unstructured":"Corsiero, E., Sutcliffe, N., Pitzalis, C. & Bombardieri, M. Accumulation of self-reactive na\u00efve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sj\u00f6gren\u2019s syndrome. PLoS ONE 9, e114575. https:\/\/doi.org\/10.1371\/journal.pone.0114575 (2014).","journal-title":"PLoS ONE"},{"key":"19397_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","volume":"10","author":"G Hernandez-Molina","year":"2011","unstructured":"Hernandez-Molina, G., Leal-Alegre, G. & Michel-Peregrina, M. The meaning of anti-Ro and anti-La antibodies in primary Sjogren\u2019s syndrome. Autoimmun. Rev. 10, 123\u2013125. https:\/\/doi.org\/10.1016\/j.autrev.2010.09.001 (2011).","journal-title":"Autoimmun. Rev."},{"key":"19397_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/08916930400022954","volume":"38","author":"F Franceschini","year":"2005","unstructured":"Franceschini, F. & Cavazzana, I. Anti-Ro\/SSA and La\/SSB antibodies. Autoimmunity 38, 55\u201363. https:\/\/doi.org\/10.1080\/08916930400022954 (2005).","journal-title":"Autoimmunity"},{"key":"19397_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","volume":"39","author":"D Cornec","year":"2012","unstructured":"Cornec, D. et al. B cells in Sj\u00f6gren\u2019s syndrome: From pathophysiology to diagnosis and treatment. J. Autoimmun. 39, 161\u2013167. https:\/\/doi.org\/10.1016\/j.jaut.2012.05.014 (2012).","journal-title":"J. Autoimmun."},{"key":"19397_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne, G. & Mariette, X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 14, 133\u2013145. https:\/\/doi.org\/10.1038\/nrrheum.2018.1 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"19397_CR52","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/art.24715","volume":"60","author":"T Suber","year":"2009","unstructured":"Suber, T. & Rosen, A. Apoptotic cell blebs: Repositories of autoantigens and contributors to immune context. Arthritis Rheum. 60, 2216\u20132219. https:\/\/doi.org\/10.1002\/art.24715 (2009).","journal-title":"Arthritis Rheum."},{"key":"19397_CR53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/rheumatology\/kep467","volume":"49","author":"MD Smith","year":"2010","unstructured":"Smith, M. D. et al. Apoptosis in the rheumatoid arthritis synovial membrane: Modulation by disease-modifying anti-rheumatic drug treatment. Rheumatology 49, 862\u2013875. https:\/\/doi.org\/10.1093\/rheumatology\/kep467 (2010).","journal-title":"Rheumatology"},{"key":"19397_CR54","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1172\/jci117051","volume":"93","author":"E Mysler","year":"1994","unstructured":"Mysler, E. et al. The apoptosis-1\/Fas protein in human systemic lupus erythematosus. J. Clin. Investig. 93, 1029\u20131034. https:\/\/doi.org\/10.1172\/jci117051 (1994).","journal-title":"J. Clin. Investig."},{"key":"19397_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clim.2009.08.012","volume":"133","author":"E Julia","year":"2009","unstructured":"Julia, E., Edo, M. C., Horga, A., Montalban, X. & Comabella, M. Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS. Clin. Immunol. 133, 364\u2013374. https:\/\/doi.org\/10.1016\/j.clim.2009.08.012 (2009).","journal-title":"Clin. Immunol."},{"key":"19397_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/art.40676","volume":"71","author":"CY Gao","year":"2019","unstructured":"Gao, C. Y. et al. Tissue-resident memory CD8+ T cells acting as mediators of salivary gland damage in a murine model of Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 71, 121\u2013132. https:\/\/doi.org\/10.1002\/art.40676 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"19397_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2249.2012.04587.x","volume":"169","author":"M Moriyama","year":"2012","unstructured":"Moriyama, M. et al. Cytokine\/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Immunol. 169, 17\u201326. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04587.x (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"19397_CR58","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/ard.2004.033837","volume":"65","author":"C Molina","year":"2006","unstructured":"Molina, C. et al. Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren\u2019s syndrome: Association with mononuclear cell infiltration. Ann. Rheum. Dis. 65, 178\u2013183. https:\/\/doi.org\/10.1136\/ard.2004.033837 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR59","doi-asserted-by":"publisher","first-page":"602823","DOI":"10.3389\/fimmu.2020.602823","volume":"11","author":"H Zhou","year":"2020","unstructured":"Zhou, H., Yang, J., Tian, J. & Wang, S. CD8(+) T lymphocytes: Crucial players in Sj\u00f6gren\u2019s syndrome. Front. Immunol. 11, 602823. https:\/\/doi.org\/10.3389\/fimmu.2020.602823 (2020).","journal-title":"Front. Immunol."},{"key":"19397_CR60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classification criteria for Sjogren\u2019s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554\u2013558. https:\/\/doi.org\/10.1136\/ard.61.6.554 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","volume":"14","author":"T Fujibayashi","year":"2004","unstructured":"Fujibayashi, T., Sugai, S., Miyasaka, N., Hayashi, Y. & Tsubota, K. Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): Availability and validity. Mod. Rheumatol. 14, 425\u2013434. https:\/\/doi.org\/10.3109\/s10165-004-0338-x (2004).","journal-title":"Mod. Rheumatol."},{"key":"19397_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski, C. H. et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 76, 9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"19397_CR63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1369\/00221554211007793","volume":"69","author":"M Willemsen","year":"2021","unstructured":"Willemsen, M., Krebbers, G., Bekkenk, M. W., Teunissen, M. B. M. & Luiten, R. M. Improvement of opal multiplex immunofluorescence workflow for human tissue sections. J. Histochem. Cytochem. 69, 339\u2013346. https:\/\/doi.org\/10.1369\/00221554211007793 (2021).","journal-title":"J. Histochem. Cytochem."},{"key":"19397_CR64","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/cyto.a.20052","volume":"59","author":"RC Ecker","year":"2004","unstructured":"Ecker, R. C. & Steiner, G. E. Microscopy-based multicolor tissue cytometry at the single-cell level. Cytom. Part A J. Int. Soc. Anal. Cytol. 59, 182\u2013190. https:\/\/doi.org\/10.1002\/cyto.a.20052 (2004).","journal-title":"Cytom. Part A J. Int. Soc. Anal. Cytol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19397-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19397-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T20:56:43Z","timestamp":1676753803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19397-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19397"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19397-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"9 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15427"}}